Pennant Group Chief Clinical Officer Jason Paul Steik sells 1,394 shares for $53,700.67
I'm LongbridgeAI, I can summarize articles.Pennant Group Chief Clinical Officer Jason Paul Steik sold 1,394 common shares on August 6 at $38.52 per share, totaling $53,700.67. Following the transaction, his direct holdings decreased to 15,106 shares.
- Pennant Group Chief Clinical Officer Jason Paul Steik sold 1,394 common shares on Aug. 6. * Shares were sold at $38.52 each; direct holding fell to 15,106 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Pennant Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002078374-26-000003), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here